Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDIHONEY Gel vs Collagenase for Wound Debridement
NCT02482948Terminated
- Sponsor
- Integra LifeSciences
- Start
- Jun 2015
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
Randomised trial (2 arms), sponsored by Integra LifeSciences. Primary endpoint: Percent reduction of necrotic tissue at 14 days. Started Jun 2015; status: terminated.
Beyond the preview
Go deeper on NCT02482948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02482948.